URINARY BLADDER NEOPLASM
Clinical trials for URINARY BLADDER NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new URINARY BLADDER NEOPLASM trials appear
Sign up with your email to follow new studies for URINARY BLADDER NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BT8009 targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests a new drug called BT8009, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have a protein called Nectin-4. The goal is to see if the drug is safe and shrinks tumors. About 329 adults with cancers like bladder, breast, lung, or…
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called LY4101174 in people with advanced or metastatic solid tumors, including bladder, breast, lung, and other cancers. The goal is to find a safe and effective dose and see if the drug can shrink tumors. About 490 participants will take p…
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 05, 2026 11:52 UTC